These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12115502)

  • 1. CHC1-L, a candidate gene for prostate carcinogenesis at 13q14.2, is frequently affected by loss of heterozygosity and underexpressed in human prostate cancer.
    Latil A; Morant P; Fournier G; Mangin P; Berthon P; Cussenot O
    Int J Cancer; 2002 Jun; 99(5):689-96. PubMed ID: 12115502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion.
    Latil A; Chêne L; Mangin P; Fournier G; Berthon P; Cussenot O
    Prostate; 2003 Sep; 57(1):39-50. PubMed ID: 12886522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
    Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
    Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression mapping at 12p12-13 in advanced prostate carcinoma.
    Kibel AS; Huagen J; Guo C; Isaacs WB; Yan Y; Pienta KJ; Goodfellow PJ
    Int J Cancer; 2004 May; 109(5):668-72. PubMed ID: 14999772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer.
    Bièche I; Lidereau R
    Mol Carcinog; 2000 Nov; 29(3):151-8. PubMed ID: 11108660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer.
    Dong JT; Boyd JC; Frierson HF
    Prostate; 2001 Nov; 49(3):166-71. PubMed ID: 11746261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cDNA cloning, gene characterization and 13q14.3 chromosomal assignment of CHC1-L, a chromosome condensation regulator-like guanine nucleotide exchange factor.
    Devilder MC; Cadoret E; Chérel M; Moreau I; Rondeau G; Bézieau S; Moisan JP
    Genomics; 1998 Nov; 54(1):99-106. PubMed ID: 9806834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer.
    Hyytinen ER; Frierson HF; Boyd JC; Chung LW; Dong JT
    Genes Chromosomes Cancer; 1999 Jun; 25(2):108-14. PubMed ID: 10337994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity at chromosome arm 13q and RB1 status in human prostate cancer.
    Latil A; Bièche I; Pesche S; Volant A; Valèri A; Fournier G; Cussenot O; Lidereau R
    Hum Pathol; 1999 Jul; 30(7):809-15. PubMed ID: 10414500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
    Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
    Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive analysis of the 7q31 region in human prostate tumors supports TES as the best candidate tumor suppressor gene.
    Chêne L; Giroud C; Desgrandchamps F; Boccon-Gibod L; Cussenot O; Berthon P; Latil A
    Int J Cancer; 2004 Sep; 111(5):798-804. PubMed ID: 15252854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelotyping analysis at chromosome 13q of high-grade prostatic intraepithelial neoplasia and clinically insignificant and significant prostate cancers.
    Lu W; Takahashi H; Furusato M; Maekawa S; Nakano M; Meng C; Kikuchi Y; Sudo A; Hano H
    Prostate; 2006 Mar; 66(4):405-12. PubMed ID: 16302266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3.
    Yin Z; Spitz MR; Babaian RJ; Strom SS; Troncoso P; Kagan J
    Oncogene; 1999 Dec; 18(52):7576-83. PubMed ID: 10602517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a I-cM region of common deletion on 13q14 associated with human prostate cancer.
    Ueda T; Emi M; Suzuki H; Komiya A; Akakura K; Ichikawa T; Watanabe M; Shiraishi T; Masai M; Igarashi T; Ito H
    Genes Chromosomes Cancer; 1999 Mar; 24(3):183-90. PubMed ID: 10451697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
    Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R
    Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there any association between nek3 and cancers with frequent 13q14 deletion?
    Hernández M; Almeida TA
    Cancer Invest; 2006 Nov; 24(7):682-8. PubMed ID: 17118778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer.
    Jarrard DF; Bova GS; Ewing CM; Pin SS; Nguyen SH; Baylin SB; Cairns P; Sidransky D; Herman JG; Isaacs WB
    Genes Chromosomes Cancer; 1997 Jun; 19(2):90-6. PubMed ID: 9171999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.
    Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H
    Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct regions of allelic loss on 13q in prostate cancer.
    Cooney KA; Wetzel JC; Merajver SD; Macoska JA; Singleton TP; Wojno KJ
    Cancer Res; 1996 Mar; 56(5):1142-5. PubMed ID: 8640774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.